Header Logo

Connection

MICHELLE A FANALE to Ipilimumab

Back to Details
This is a "connection" page, showing publications MICHELLE A FANALE has written about Ipilimumab.
MICHELLE A FANALE
Connection Strength
0.028
Ipilimumab
  1. Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers. Mol Cancer Ther. 2018 03; 17(3):671-676.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.